A 9-LncRNA Signature for Predicting Prognosis and Immune Response in Diffuse Large B-Cell Lymphoma

Diffuse large B-cell lymphoma (DLBCL) is a biologically and clinically heterogeneous disease that requires personalized clinical treatment. To assign patients into different risk categories, cytogenetic abnormalities and genetic mutations have been widely applied to the prognostic stratification of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xiaoxuan, Lu, Yaxiao, Liu, Ziyi, Zhang, Yidan, He, You, Sun, Cong, Li, Lanfang, Zhai, Qiongli, Meng, Bin, Ren, Xiubao, Wu, Xudong, Zhang, Huilai, Wang, Xianhuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298982/
https://www.ncbi.nlm.nih.gov/pubmed/35874768
http://dx.doi.org/10.3389/fimmu.2022.813031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298982/
https://www.ncbi.nlm.nih.gov/pubmed/35874768
http://dx.doi.org/10.3389/fimmu.2022.813031

Ejemplares similares